164 related articles for article (PubMed ID: 21822708)
1. Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention.
Ogita M; Sakakura K; Nakamura T; Funayama H; Wada H; Naito R; Sugawara Y; Kubo N; Ako J; Momomura S
Heart Vessels; 2012 Sep; 27(5):460-7. PubMed ID: 21822708
[TBL] [Abstract][Full Text] [Related]
2. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
[TBL] [Abstract][Full Text] [Related]
3. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
[TBL] [Abstract][Full Text] [Related]
4. Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease.
Deguchi Y; Saito Y; Nakao M; Shiraishi H; Sakamoto N; Kobayashi S; Kobayashi Y
Heart Vessels; 2021 Mar; 36(3):315-320. PubMed ID: 32930865
[TBL] [Abstract][Full Text] [Related]
5. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
6. Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.
Baber U; Giustino G; Sartori S; Aquino M; Stefanini GG; Steg PG; Windecker S; Leon MB; Wijns W; Serruys PW; Valgimigli M; Stone GW; Dangas GD; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari D; Von Birgelen C; Mastoris I; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
JACC Cardiovasc Interv; 2016 Jan; 9(1):28-38. PubMed ID: 26762908
[TBL] [Abstract][Full Text] [Related]
7. Long-term renal outcomes after elective percutaneous coronary intervention in patients with advanced renal dysfunction.
Tashiro H; Tanaka A; Ishii H; Takagi K; Uemura Y; Inoue Y; Umemoto N; Negishi Y; Shibata N; Yoshioka N; Shimizu K; Morishima I; Watarai M; Asano H; Murohara T;
Heart Vessels; 2021 Apr; 36(4):452-460. PubMed ID: 33151381
[TBL] [Abstract][Full Text] [Related]
8. Impact of continuous deterioration of kidney function 6 to 8 months after percutaneous coronary intervention for acute coronary syndrome.
Nemoto N; Iwasaki M; Nakanishi M; Araki T; Utsunomiya M; Hori M; Ikeda N; Makino K; Itaya H; Iijima R; Hara H; Takagi T; Joki N; Sugi K; Nakamura M
Am J Cardiol; 2014 May; 113(10):1647-51. PubMed ID: 24656479
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Renal Dysfunction.
Malik AO; Spertus JA; Grantham JA; Peri-Okonny P; Gosch K; Sapontis J; Moses J; Lombardi W; Karmpaliotis D; Nicholson WJ; Al Badarin F; Salisbury AC
Am J Cardiol; 2020 Apr; 125(7):1046-1053. PubMed ID: 31955832
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion.
Gong ML; Mao Y; Liu JH
Chin Med J (Engl); 2020 Dec; 134(3):302-308. PubMed ID: 33522726
[TBL] [Abstract][Full Text] [Related]
11. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Lipoprotein (a) for Predicting Outcomes After Percutaneous Coronary Intervention for Stable Angina Pectoris in Patients on Hemodialysis.
Hishikari K; Hikita H; Yoshikawa H; Abe F; Tsujihata S; Ito N; Kanno Y; IIya M; Murai T; Takahashi A; Yonetsu T; Sasano T
Am J Cardiol; 2020 Dec; 136():32-37. PubMed ID: 32941820
[TBL] [Abstract][Full Text] [Related]
13. The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion.
Di Serafino L; Borgia F; Maeremans J; Pyxaras SA; De Bruyne B; Wijns W; Heyndrickx G; Dens J; Di Mario C; Barbato E
Am J Cardiol; 2014 Oct; 114(8):1158-64. PubMed ID: 25152423
[TBL] [Abstract][Full Text] [Related]
14. Impact of serum albumin levels on long-term outcomes in patients undergoing percutaneous coronary intervention.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Heart Vessels; 2017 Sep; 32(9):1085-1092. PubMed ID: 28429111
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognosis of percutaneous coronary intervention-associated nephropathy in patients with acute coronary syndrome and normal kidney function.
Hernando L; Canovas E; Freites A; de la Rosa A; Alonso J; del Castillo R; Salinas P; Montalvo GB; Huelmos AI; Botas J
Rev Esp Cardiol (Engl Ed); 2015 Apr; 68(4):310-6. PubMed ID: 25263104
[TBL] [Abstract][Full Text] [Related]
16. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T
Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293
[TBL] [Abstract][Full Text] [Related]
17. Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.
Wada H; Ogita M; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Suwa S; Daida H
Heart Vessels; 2017 Jan; 32(1):16-21. PubMed ID: 27107767
[TBL] [Abstract][Full Text] [Related]
18. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
[TBL] [Abstract][Full Text] [Related]
19. ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
Lee MS; Lee AC; Shlofmitz RA; Martinsen BJ; Hargus NJ; Elder MD; Généreux P; Chambers JW
Catheter Cardiovasc Interv; 2017 Apr; 89(5):841-848. PubMed ID: 27567020
[TBL] [Abstract][Full Text] [Related]
20. The burden of major adverse cardiac events in patients with coronary artery disease.
Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
